Index
Module 13 • GI/Endocrine
Hepatic Failure, GI & Endocrine Emergencies
6%
Data Tables
Hepatic Failure, GI & Endocrine Emergencies
Stephanie N. Bass ~4 min read Module 13 of 20
4
/ 65

Hepatic Failure/GI/Endocrine Emergencies

3

A 46-year-old man presents with alcohol-induced

severe acute pancreatitis (AP). Pertinent medical

history includes alcoholic cirrhosis and several admis-

sions for aspiration pneumonia secondary to hepatic

encephalopathy. He is given intravenous fluids for ini-

tial volume resuscitation with lactated Ringer solution.

Which action would be best for the patient’s nutrition?

A.Give nothing by mouth (i.e., kept NPO) to rest

the pancreas until AP is resolved.

B.Initiate total parenteral nutrition (TPN).
C.Give enteral feeding by the nasogastric (NG)

route.

D.Give enteral feeding by the nasojejunal (NJ)

route.

4

A 37-year-old woman presents after a Roux-en-Y

gastric bypass for morbid obesity. Her postoperative

course was complicated by the formation of an entero-

cutaneous fistula, fevers, and leukocytosis. She was

initiated on broad-spectrum antibiotics, and a wound

vacuum-assisted closure was placed on her fistula site

to help with drainage and healing. Her fistula output

was 570 mL/day yesterday, and today, it was 250 mL/

day. Which statement is most accurate regarding her

fistula output between the two recordings?

A.Her output would be defined as a low output on

both days.

B.Her output would be defined as a high output

that has converted to a low output.

C.Her output would be defined as a high output

that has converted to a moderate output.

D.Her output would be considered moderate on

both days.

5

A 68-year-old man presents for a large bowel resec-

tion. Given the high incidence of postoperative ileus

(POI) with this procedure, he is initiated on alvimo-

pan before surgery. To reduce the cardiovascular risk

associated with alvimopan, the U.S. Food and Drug

Administration (FDA) placed a restriction on alvi-

mopan use that has been implemented through the

EASE (ENTEREG Access Support & Education)

program. Which best represents that restriction?

A.Start continuous electrocardiogram (ECG)

monitoring on initiation to monitor for cor-

rected QT (QTc) prolongation.

B.Use is restricted to short term with a limit of

15 doses.

C.Decrease alvimopan dose to 6 mg twice daily.
D.Use is contraindicated in patients with previous

myocardial infarction.

6

A 40-year-old woman presents for elective abdomi-

nal surgery to remove a malignancy from her liver.

Given the extensiveness of the surgery, the expected

use of volatile anesthetics, and the use of periop-

erative opioids, a multimodal plan is developed to

avoid postoperative nausea and vomiting (PONV).

Which best describes the timing of prophylactic

administration with respect to surgery?

A.Dexamethasone 4 mg intravenously given at

the end of surgery.

B.Ondansetron 4 mg intravenously given when

inducing anesthesia.

C.Neurokinin-1 receptor antagonist (aprepitant

40–125 mg) given at the end of surgery.

D.Droperidol 0.625–1.25 mg intravenously given

at the end of surgery.

7

A 69-year-old woman presents to the surgical inten-

sive care unit (ICU) at your institution with upper

gastrointestinal bleeding (UGIB) caused by a gas-

tric ulcer. She has lost a significant amount of blood

because of the bleed and currently requires blood

transfusions. As part of her diagnostic workup to

determine the etiology of her ulcer, she tests posi-

tive for a Helicobacter pylori infection. Which best

reflects an inappropriate treatment option for her?

A.Octreotide 50 mcg bolus, followed by 50 mcg/

hour for 72 hours.

B.Treatment with a proton pump inhibitor (PPI)/

antibiotic combination for 14 days.

C.A therapeutic endoscopy within 24 hours.
D.Blood transfusions to maintain hemoglobin

greater than 7 g/dL.

8

Which set of laboratory abnormalities best reflects

those that patients in thyroid storm typically present

with?

A.High thyroid-stimulating hormone (TSH),

triiodothyronine (T3), and thyroxine (T4)

concentrations.

B.Low TSH, high T3, and high T4 concentrations.
C.Low TSH, high T3, and low T4 concentrations.
D.Low TSH, low T3, and low T4 concentrations.
Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 3 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube